SCHEMBL14680928

SCHEMBL14680928

c1ccc(CCc2ncc(-c3ccccc3)o2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.64
RXRA P19793 1/20 0.60
RXRB P28702 1/20 0.60
RXRG P48443 1/20 0.60
HRH3 Q9Y5N1 1/20 0.54
FFAR1 O14842 1/20 0.53
HDAC3 O15379 1/20 0.52
HDAC4 P56524 1/20 0.52
HDAC1 Q13547 1/20 0.52
HDAC7 Q8WUI4 1/20 0.52
HDAC2 Q92769 1/20 0.52
HDAC10 Q969S8 1/20 0.52
HDAC11 Q96DB2 1/20 0.52
HDAC8 Q9BY41 1/20 0.52
HDAC6 Q9UBN7 1/20 0.52
HDAC9 Q9UKV0 1/20 0.52
HDAC5 Q9UQL6 1/20 0.52
FAAH O00519 5/20 0.51
CES1 P23141 1/20 0.51
ALOX15 P16050 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26616389 0.90 NOTUM (0.60) NOTUMRXRARXRBRXRGHRH3
SCHEMBL15427231 0.82 NOTUM (0.64) NOTUMRXRARXRBRXRGHRH3
SCHEMBL5540110 0.82 NOTUM (0.64) NOTUMRXRARXRBRXRGHRH3
SCHEMBL11552080 0.82 NOTUM (0.64) NOTUMRXRARXRBRXRGHRH3
SCHEMBL5545105 0.81 HRH3 (0.60) NOTUMRXRARXRBRXRGHRH3
SCHEMBL5541886 0.79 NOTUM (0.60) NOTUMRXRARXRBRXRGHRH3
SCHEMBL15621589 0.79 NOTUM (0.60) NOTUMRXRARXRBRXRGHRH3
SCHEMBL15810189 0.78 RXRA (0.60) NOTUMRXRARXRBRXRGHRH3
SCHEMBL103246 0.78 NOTUM (0.58) NOTUMRXRARXRBRXRGHRH3
SCHEMBL15617687 0.78 NOTUM (0.58) NOTUMRXRARXRBRXRGHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8962665-B2 Thiazole and oxazole kinase inhibitors AB SCIENCE (FR) 2015-02-24 US disclosed
US-20130035331-A1 THIAZOLE AND OXAZOLE KINASE INHIBITORS AB SCIENCE (FR) 2013-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130035331-A1 THIAZOLE AND OXAZOLE KINASE INHIBITORS SYK, LTK, MERTK NOTUM 2301/4885RXRA 4199/4885RXRB 3871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.